MedTrace Logo

Clinical Performance of MTA Cavity Lining in the Treatment of Deep Caries Lesions

NCT04018716 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 73

Last updated 2019-07-16

No results posted yet for this study

Summary

Aim of this clinical study is to compare the clinical success of two lining materials regarding the maintenance of pulp vitality in the treatment of deep caries lesions over 4- years.

A hundred permanent premolar and molars with deep caries lesions without pulp involvement (aged between 18 and 30 years) in 73 patients were randomly divided into the following groups: calcium hydroxide cement (Ca(OH)2) (Dycal, Dentsply/Caulk, Dentsply International Inc, Milford, DE, USA) group and mineral trioxide aggregate (MTA) (Dentsplay, Tulsa Dental, Johnson city, USA) group. Final restoration with a resin-based composite (Gradia Direct Posterior, GC, Tokyo, Japan) in a single session was performed. The following-up period was 6-, 12-, 24-, 36- and 48-months. Two calibrated examiners performed the clinical examination of the pulpal symptoms

Conditions

  • Mineral Trioxide Aggregate
  • Calcium Hydroxide
  • Indirect Pulp Capping

Interventions

DEVICE

MTA

Indirect capping with MTA

DEVICE

Dycal

Indirect capping with Dycal

Sponsors & Collaborators

  • Hacettepe University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
30 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-07-07
Primary Completion
2016-01-07
Completion
2019-07-07

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04018716 on ClinicalTrials.gov